等待开盘 10-22 09:30:00 美东时间
+0.040
+0.57%
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule
10-09 19:35
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock moved upwards by 137.1% to $10...
10-09 01:06
Shares of Confluent Inc (NASDAQ:CFLT) rose sharply in pre-market trading. Confl...
10-08 16:43
今日重点评级关注:Maxim Group:上调Adial Pharmaceuticals评级至"买入",目标价1.5美元;BTIG:维持Climb Bio"买入"评级,目标价从7美元升至8美元
10-01 20:13
The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on Acurx's Pediatric Investigation Plan (PIP) for ibezapolstat use in children with C. difficile infectionReceipt of this
09-30 19:34
Acurx Pharmaceuticals ( ($ACXP) ) just unveiled an update. On September 16, 202...
09-23 04:57
An announcement from Acurx Pharmaceuticals ( ($ACXP) ) is now available. On Sep...
09-20 05:47
Acurx Pharmaceuticals (NASDAQ:ACXP) has regained compliance with Nasdaq’s minimum closing bid price and minimum stockholders' equity threshold requirements for continued listing on the exchange. The c...
09-03 19:42
HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target from $8 to $31.
08-12 22:41
Acurx Pharmaceuticals press release (NASDAQ:ACXP): Q2 GAAP EPS of -$1.89. The company ended the quarter with cash totaling $6.1 million, compared to $3.7 million as of December 31, 2024. More on Acu...
08-12 19:10